Upon completion of its acquisition of Allergan, AbbVie will create a new global business, called Allergan Aesthetics. Allergan Aesthetics will have its own research and development function under the AbbVie umbrella and will include leading aesthetic products including, BOTOX Cosmetic, the JUVEDERM collection of dermal fillers and COOLSCULPTING body contouring, among others. Located in Irvine, California, the new company will be led by Carrie Strom, current senior vice president, U.S. Medical Aesthetics, Allergan. Upon completion of the Allergan acquisition, Strom will be named senior vice president of AbbVie and president of Global Allergan Aesthetics. She will oversee the worldwide operations, along with an experienced team of current Allergan leaders, and report directly to Richard A. Gonzalez, chairman and CEO of AbbVie.
The “Eye Care and Specialty” businesses, including BOTOX Therapeutics, Central Nervous System, Women’s Health and Gastrointestinal Diseases, will be integrated into the existing AbbVie organization.
The following individuals will make up the executive leadership team of the combined companies:
- Richard A. Gonzalez, chairman and CEO
- Laura Schumacher, vice chairman,...